Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Botulinum toxin type A 100unit/vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Botulinum toxin type A 500 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Product containing clostridium botulinum A toxin-hemagglutinin complex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Botulinum toxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Product containing botulinum toxin type A (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Foodborne botulism, type A (disorder) |
Causative agent (attribute) |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
AbobotulinumtoxinA (substance) |
Is a |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
OnabotulinumtoxinA (substance) |
Is a |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Botulinum toxin type A 500 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
IncobotulinumtoxinA (substance) |
Is a |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
|
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 500 unit powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 500 unit powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing only botulinum toxin type A (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing only botulinum toxin type A in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 100 unit powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 100 unit powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing precisely botulinum toxin type A 50 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing precisely botulinum toxin type A 50 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 125 unit powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Botulinum toxin type A 125 unit powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Injection of botulinum toxin type A into nasal turbinate |
Direct substance |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Injection of botulinum toxin type A into detrusor muscle of urinary bladder (procedure) |
Direct substance |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing precisely botulinum toxin type A 200 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Product containing precisely botulinum toxin type A 200 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |
Injection of botulinum toxin type A into sphincter urethrae muscle (procedure) |
Direct substance |
True |
Botulinum toxin type A |
Inferred relationship |
Some |
1 |